These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30648695)

  • 1. Bisphenol A levels are negatively correlated with serum vitamin D-binding protein and sex hormone-binding globulin levels in women with polycystic ovary syndrome: a pilot study.
    Jędrzejuk D; Kuliczkowska-Płaksej J; Milewicz A; Wilczewska K; Namieśnik J; Rutkowska A
    Pol Arch Intern Med; 2019 Feb; 129(2):133-136. PubMed ID: 30648695
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.
    Tarantino G; Valentino R; Di Somma C; D'Esposito V; Passaretti F; Pizza G; Brancato V; Orio F; Formisano P; Colao A; Savastano S
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):447-53. PubMed ID: 22805002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome.
    Konieczna A; Rachoń D; Owczarek K; Kubica P; Kowalewska A; Kudłak B; Wasik A; Namieśnik J
    Reprod Toxicol; 2018 Dec; 82():32-37. PubMed ID: 30266220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bisphenol-A concentration and sex hormone levels in men.
    Zhou Q; Miao M; Ran M; Ding L; Bai L; Wu T; Yuan W; Gao E; Wang J; Li G; Li DK
    Fertil Steril; 2013 Aug; 100(2):478-82. PubMed ID: 23651625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls.
    Akın L; Kendirci M; Narin F; Kurtoglu S; Saraymen R; Kondolot M; Koçak S; Elmali F
    Acta Paediatr; 2015 Apr; 104(4):e171-7. PubMed ID: 25469562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
    Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
    Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.
    Vahedi M; Saeedi A; Poorbaghi SL; Sepehrimanesh M; Fattahi M
    Environ Sci Pollut Res Int; 2016 Dec; 23(23):23546-23550. PubMed ID: 27614642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma androgens and sex hormone binding globulin in women with polycystic ovaries diagnosed by transvaginal ultrasound.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    J Reprod Med; 1993 Nov; 38(11):858-62. PubMed ID: 8277481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
    Palioura E; Diamanti-Kandarakis E
    Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis.
    Hu Y; Wen S; Yuan D; Peng L; Zeng R; Yang Z; Liu Q; Xu L; Kang D
    Gynecol Endocrinol; 2018 May; 34(5):370-377. PubMed ID: 29191127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extremely low SHBG level in consequence of Pro156Leu SHBG polymorphism--case reports of two women with polycystic ovary syndrome].
    Vanková M; Prazáková S; Lukásová P; Vcelák J; Vejrazková D; Bradnová O; Dvoráková K; Vrbíková J; Bendlová B
    Vnitr Lek; 2010 Dec; 56(12):1292-5. PubMed ID: 21261118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].
    Li TT; Xu LZ; Chen YH; Deng HM; Liang CY; Liu Y; Liu XF; Zhang J; Kang DY; Qiu DS; Han DW; Hu R
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1753-6. PubMed ID: 22027783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
    Kozakowski J; Kapuścińska R; Zgliczyński W
    Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis.
    Deswal R; Yadav A; Dang AS
    Syst Biol Reprod Med; 2018 Feb; 64(1):12-24. PubMed ID: 29227165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats.
    Yang Z; Shi J; Guo Z; Chen M; Wang C; He C; Zuo Z
    Chemosphere; 2019 Sep; 231():151-160. PubMed ID: 31129395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter re: The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.
    Puder JJ; Müller B; Keller U
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4419-20. PubMed ID: 16002415
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH; Wang TW; Wei HJ; Hsu CY; Ho HJ; Chen WH; Young R; Liaw CM; Chao JC
    Br J Nutr; 2013 Jun; 109(12):2190-8. PubMed ID: 23046530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
    Kandaraki E; Chatzigeorgiou A; Livadas S; Palioura E; Economou F; Koutsilieris M; Palimeri S; Panidis D; Diamanti-Kandarakis E
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E480-4. PubMed ID: 21193545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.